Eli Lilly and Company (LLY) Key Ratios

$1,364.73

up-down-arrow $-53.26 (-3.76%)

As on 05-Nov-2026 16:28EST

Market cap

info icon

$1,262,667 Mln

Revenue (TTM)

info icon

$86,462 Mln

P/E Ratio

info icon

46.1

P/B Ratio

info icon

31.4

Div. Yield

info icon

0.5 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 6.19 38.61 45.51 39.18 25.51
EBIT -29.49 18.51 70.32 86.40 42.95
Net Profit -9.08 15.56 49.79 79.37 35.99
EPS -9.05 16.26 50.65 80.33 37.30
Book Value -- -- 88.04 38.15 38.03
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info 34.6730.3949.2445.5637.83
Net Margin info --22.1331.90----
Return on equity info 78.3875.0277.18101.3684.84
Return on Capital info 25.7524.83--35.3225.26
Return on Assets info 15.2214.0115.7521.5914.84
Debt to Equity (x) info ----1.171.602.37
ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
--
35.32
25.26
16.67
23.68
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

77.18

Higher than Peers by 57.45

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
77.18
101.36
84.84
48.93
63.63
Peer Median
19.73
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

15.75

Higher than Peers by 12.90

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
15.75
21.59
14.84
9.23
12.71
Peer Median
2.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

49.24

Higher than Peers by 33.66

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
49.24
45.56
37.83
20.63
25.01
Peer Median
15.58
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

31.90

Higher than Peers by 23.56

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
31.90
31.67
23.51
15.36
22.13
Peer Median
8.34
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Revenue Growth

45.51

Higher than Peers by 37.67

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
45.51
0.45
0.32
0.20
0.01
Peer Median
7.83
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

70.32

Higher than Peers by 62.95

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
70.32
74.27
142.03
-1.37
9.89
Peer Median
7.38
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

49.79

Higher than Peers by 43.26

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
49.79
94.90
102.08
-16.08
11.88
Peer Median
6.53
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

50.65

Higher than Peers by 42.52

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
50.65
0.96
1.02
-0.12
0.12
Peer Median
8.13
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

70.28

Higher than Peers by 65.40

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
70.28
--
--
--
--
Peer Median
4.87
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Debt to Equity

1.17

Higher than Peers by 0.61

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
1.17
1.60
2.37
2.34
1.52
Peer Median
0.55
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.06

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
0.06
0.06
0.36
0.64
0.14
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

1.39

Lower than Peers by 0.26

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
1.39
1.58
1.15
0.94
1.05
Peer Median
1.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.00

Lower than Peers by 0.21

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
1.00
1.19
0.89
0.73
0.80
Peer Median
1.21
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

30.52

Higher than Peers by 25.53

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
30.52
37.34
21.83
14.49
21.53
Peer Median
4.98
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

29.18

Higher than Peers by 8.58

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
29.18
30.92
29.47
33.22
29.99
Peer Median
20.61
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.49

Higher than Peers by 0.09

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
0.49
0.68
0.63
0.60
0.58
Peer Median
0.40
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
--
93.67
99.79
106.47
106.77
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
--
352.51
289.88
259.99
225.76
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
--
142.23
126.42
116.80
99.20
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
--
303.95
263.25
249.67
233.33
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Earnings

46.11

Higher than Peers by 2.22

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
46.11
46.76
65.84
100.55
55.66
Peer Median
43.90
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

31.35

Higher than Peers by 23.35

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
31.35
36.37
49.13
48.92
32.64
Peer Median
8.00
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

0.49

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
0.49
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

28.12

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
28.12
31.56
38.68
64.11
41.76
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

1,262,667

Higher than Peers by 1,260,226

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Eli Lilly and Company (LLY)
1,262,667
--
--
--
--
Peer Median
2,440
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month